Genenta Science S.P.A. ADR (GNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,958 | 3,995 | 31,392 | 44,059 | 17,666 |
| Marketable Securities | 8,741 | 16,326 | N/A | N/A | N/A |
| TOTAL | $15,661 | $23,006 | $33,422 | $45,856 | $18,887 |
| Non-Current Assets | |||||
| PPE Net | 46 | 90 | 118 | 27 | 22 |
| Other Non-Current Assets | 333 | 1,091 | 1,691 | 1,473 | 1,084 |
| TOTAL | $380 | $1,181 | $1,809 | $1,500 | $1,106 |
| Total Assets | $16,041 | $24,186 | $35,230 | $47,356 | $19,993 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 539 | 504 | 1,258 | 225 | 634 |
| Accrued Expenses | 1,367 | 1,098 | 729 | 999 | 1,971 |
| Other current liabilities | 366 | 276 | 314 | 119 | 61 |
| TOTAL | $2,272 | $1,879 | $2,301 | $1,343 | $2,666 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 248 | 194 | 122 | 36 | 20 |
| TOTAL | $248 | $194 | $122 | $36 | $20 |
| Total Liabilities | $2,519 | $2,073 | $2,423 | $1,379 | $2,685 |
| Shareholders' Equity | |||||
| Common Shares | 74,083 | 72,887 | 70,174 | 77,944 | 42 |
| Retained earnings | -60,658 | -51,023 | -37,367 | -31,967 | -24,549 |
| Other shareholders' equity | 96 | 250 | 0 | 0 | 0 |
| TOTAL | $13,522 | $22,114 | $32,807 | $45,977 | $17,307 |
| Total Liabilities And Equity | $16,041 | $24,186 | $35,230 | $47,356 | $19,993 |